Ajanta Pharma Limited — Dividend/Bonus, 28-10-2024: Dividend

Ajanta Pharma reported strong financial performance in Q2 FY 2025, with consolidated revenue growing 15% to ₹1,187 crore. The company approved an interim dividend of ₹28 per share, totaling ₹350 crore. Notable gains included a 14% revenue increase for H1 FY 2025 compared to the previous year, alongside a robust EBITDA margin of 28%. Ajanta continues to see growth in its branded generic business across India, Asia, and Africa, while maintaining focus on R&D and sustainability initiatives.